Brief: Pharvaris NV - Expects Rapide-3 Data Announcement In Q4 2025
10/07/2025 11:53
July 10 (Reuters) - Pharvaris NV PHVS.O: PHARVARIS NV - EXPECTS RAPIDE-3 DATA ANNOUNCEMENT IN Q4 2025 PHARVARIS NV - PLANS NDA SUBMISSION TO FDA IN H1 2026 Source text: ID:nGNX9NVhSP Further company coverage: PHVS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharvaris
See all newsU.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, Novartis
Pharvaris gains after genetic disorder drug meets late-stage trial goal